MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/j.1399-0012.2004.00117.x

Медицинская библиотека · Clinical transplantation · 2004

Long-term outcome of liver transplantation for autoimmune hepatitis.

Vogel Arndt, Heinrich Eyk, Bahr Matthias J, Rifai Kinan, Flemming Peer, Melter Michael, Klempnauer Juergen, Nashan Björn, Manns Michael P, Strassburg Christian P

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Liver transplantation is the final therapeutic option for about 10% of patients with autoimmune hepatitis (AIH) who do not respond to medical therapy. The aim of this study was to evaluate the long-term outcome in serologically defined subgroups of AIH after transplantation.

METHODS

Pre- and post-transplantation data of 28 patients with AIH transplanted between 1987 and 1999 were retrospectively analyzed and compared with 24 patients, who underwent liver transplantation because of Wilson's disease and glycogen storage disease type 1.

RESULTS

Serological analyses identified patients with AIH type 1 (n = 13), type 2 (n = 5), and type 3 (n = 10). The 5-yr patient survival rate after liver transplantation was 78.2%, which was not significantly different from the control group. Six AIH patients and four control patients required re-transplantation because of initial non-function, chronic rejection or AIH recurrence. Patients transplanted for AIH (88%) had more episodes of acute rejection when compared with patients transplanted for genetic liver diseases (50%). Clinical and histological features of chronic rejection were present in four patients, which did not differ significantly from the controls. Recurrence of AIH was diagnosed in nine patients (32%) based upon the presence of autoantibodies, increased gamma-globulins, steroid dependency, and histological evidence of chronic hepatitis. These combined features were not found in any of the controls.

CONCLUSIONS

Our data do not suggest that AIH subtypes influence prognosis after liver transplantation. Despite a high frequency of acute cellular rejection episodes and disease recurrence, transplantation for AIH has a 5-yr survival rate, which does not differ from that observed in patients transplanted for genetic liver diseases.

Для цитирования: Vogel Arndt, Heinrich Eyk, Bahr Matthias J, Rifai Kinan, Flemming Peer, Melter Michael, Klempnauer Juergen, Nashan Björn, Manns Michael P, Strassburg Christian P. Long-term outcome of liver transplantation for autoimmune hepatitis.. Clinical transplantation. 2004. DOI: 10.1111/j.1399-0012.2004.00117.x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.